These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 24910034

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
    Liu X, Zhang Z, Jiang Y, Hu Y, Wang Z, Liu J, Feng R, Zhang J, Huang G.
    Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D, Liu Z, Wang L, Zhang C, Zhang N.
    Colloids Surf B Biointerfaces; 2011 Jul 01; 85(2):262-9. PubMed ID: 21435845
    [Abstract] [Full Text] [Related]

  • 9. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
    Su Z, Niu J, Xiao Y, Ping Q, Sun M, Huang A, You W, Sang X, Yuan D.
    Mol Pharm; 2011 Oct 03; 8(5):1641-51. PubMed ID: 21770405
    [Abstract] [Full Text] [Related]

  • 10. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
    Safwat S, Ishak RAH, Hathout RM, Mortada ND.
    Drug Dev Ind Pharm; 2017 Jul 03; 43(7):1112-1125. PubMed ID: 28276784
    [Abstract] [Full Text] [Related]

  • 11. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A.
    Wang L, Luo Q, Lin T, Li R, Zhu T, Zhou K, Ji Z, Song J, Jia B, Zhang C, Chen W, Zhu G.
    Drug Dev Ind Pharm; 2015 Jul 03; 41(7):1204-12. PubMed ID: 25010850
    [Abstract] [Full Text] [Related]

  • 12. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
    Zhang S, Wang J, Pan J.
    Drug Deliv; 2016 Nov 03; 23(9):3696-3703. PubMed ID: 27749105
    [Abstract] [Full Text] [Related]

  • 13. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
    Zhou J, Sun M, Jin S, Fan L, Zhu W, Sui X, Cao L, Yang C, Han C.
    Drug Deliv; 2019 Dec 03; 26(1):281-289. PubMed ID: 30880491
    [Abstract] [Full Text] [Related]

  • 14. Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines.
    Nahak P, Gajbhiye RL, Karmakar G, Guha P, Roy B, Besra SE, Bikov AG, Akentiev AV, Noskov BA, Nag K, Jaisankar P, Panda AK.
    Pharm Res; 2018 Aug 27; 35(10):198. PubMed ID: 30151753
    [Abstract] [Full Text] [Related]

  • 15. Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.
    Wang Z, Wang J, Yang S, Hou S.
    Drug Dev Ind Pharm; 2016 Jan 27; 42(1):91-98. PubMed ID: 25853294
    [Abstract] [Full Text] [Related]

  • 16. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
    Doktorovová S, Araújo J, Garcia ML, Rakovský E, Souto EB.
    Colloids Surf B Biointerfaces; 2010 Feb 01; 75(2):538-42. PubMed ID: 19879736
    [Abstract] [Full Text] [Related]

  • 17. FA-loaded lipid drug delivery systems: preparation, characterization and biological studies.
    Carbone C, Campisi A, Musumeci T, Raciti G, Bonfanti R, Puglisi G.
    Eur J Pharm Sci; 2014 Feb 14; 52():12-20. PubMed ID: 24514450
    [Abstract] [Full Text] [Related]

  • 18. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R, Li YZ, Chen C, Cao YN, Yu MM, Xu L, He B, Jie X, Shen WW, Wang YN, van Dongen MA, Liu GQ, Banaszak Holl MM, Zhang Q, Ke X.
    J Control Release; 2015 Jul 28; 210():160-8. PubMed ID: 26003044
    [Abstract] [Full Text] [Related]

  • 19. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y, Pan L, Jiang M, Li D, Jin L.
    Drug Deliv; 2016 May 28; 23(4):1383-92. PubMed ID: 26066035
    [Abstract] [Full Text] [Related]

  • 20. Polyarginine and PEG-AEYLR comodified nanostructured lipid carrier: 10mol% uncleavable PEG-AEYLR showed no shielding effect to polyarginine in vitro while maintaining good tumor targeting in vivo.
    Sun M, Zhu Z, Wang H, Jin S, Yang X, Han C, Pan W.
    Artif Cells Nanomed Biotechnol; 2018 Mar 28; 46(2):284-292. PubMed ID: 28355889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.